Nobu Oshima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nobu Oshima has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Albert P. Chen
GE Healthcare, Toronto, Canada
1 shared publication - Galen D. Reed
GE Healthcare, Dallas, TX 75390, USA
1 shared publication Hellmut Merkle
National Institute of Neurological Disorders and Stroke
1 shared publication- James B. Mitchell
Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication - Jan Henrik Ardenkjaer-Larsen
Department of Health Technology Technical University of Denmark Kongens Lyngby Denmark
1 shared publication - Jeeva Munasinghe
Mouse Imaging Facility, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
1 shared publication
Latest Publications
- Open Access
Distinguishing Closely Related Pancreatic Cancer Subtypes In Vivo by 13C Glucose MRI without Hyperpolarization
Metabolic differences between patients and within the tumor itself can be an important determinant in cancer treatment outcome. However, methods for determining these differences non-invasively in vivo have been lacking. Using pancreatic ductal adenocarcinoma as a model, we demonstrate that tumor xenografts with a similar genetic background can be distinguished by their differing rates of metabolism, as detected by imaging of uniformly 13 C labeled glucose tracers using a newly developed technique using tensor decomposition for noise suppression to bring the signal to a detectable level without hyperpolarization of the tracer. Using this method, cancer subtypes that appeared to exhibit similar metabolic profiles by other techniques that measured steady state metabolism can be distinguished.
Open AccessDistinguishing Closely Related Pancreatic Cancer Subtypes In Vivo by 13C Glucose MRI without Hyperpolarization
Metabolic differences between patients and within the tumor itself can be an important determinant in cancer treatment outcome. However, methods for determining these differences non-invasively in vivo have been lacking. Using pancreatic ductal adenocarcinoma as a model, we demonstrate that tumor xenografts with a similar genetic background can be distinguished by their differing rates of metabolism, as detected by imaging of uniformly 13 C labeled glucose tracers using a newly developed technique using tensor decomposition for noise suppression to bring the signal to a detectable level without hyperpolarization of the tracer. Using this method, cancer subtypes that appeared to exhibit similar metabolic profiles by other techniques that measured steady state metabolism can be distinguished.